MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 228 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.28 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,953 | -12.2% | 75 | +38.9% | 0.00% | – |
| Q2 2023 | $12,474 | +267.7% | 54 | +285.7% | 0.00% | – |
| Q1 2023 | $3,392 | -16.5% | 14 | 0.0% | 0.00% | – |
| Q4 2022 | $4,064 | – | 14 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 14 | 0.0% | 0.00% | – |
| Q2 2022 | $2,000 | 0.0% | 14 | 0.0% | 0.00% | – |
| Q1 2022 | $2,000 | -33.3% | 14 | -30.0% | 0.00% | – |
| Q4 2021 | $3,000 | +50.0% | 20 | +5.3% | 0.00% | – |
| Q3 2021 | $2,000 | 0.0% | 19 | -5.0% | 0.00% | – |
| Q2 2021 | $2,000 | 0.0% | 20 | -9.1% | 0.00% | – |
| Q1 2021 | $2,000 | 0.0% | 22 | +10.0% | 0.00% | – |
| Q4 2020 | $2,000 | 0.0% | 20 | 0.0% | 0.00% | – |
| Q3 2020 | $2,000 | 0.0% | 20 | 0.0% | 0.00% | – |
| Q2 2020 | $2,000 | – | 20 | +42.9% | 0.00% | – |
| Q1 2020 | $0 | -100.0% | 14 | 0.0% | 0.00% | – |
| Q4 2019 | $2,000 | 0.0% | 14 | 0.0% | 0.00% | – |
| Q3 2019 | $2,000 | 0.0% | 14 | 0.0% | 0.00% | – |
| Q2 2019 | $2,000 | 0.0% | 14 | 0.0% | 0.00% | – |
| Q1 2019 | $2,000 | 0.0% | 14 | 0.0% | 0.00% | – |
| Q4 2018 | $2,000 | -99.3% | 14 | -99.0% | 0.00% | – |
| Q3 2018 | $293,000 | -24.3% | 1,371 | -1.1% | 0.00% | – |
| Q2 2018 | $387,000 | +73.5% | 1,386 | -27.2% | 0.00% | – |
| Q1 2018 | $223,000 | – | 1,905 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tao Capital Management LP | 77,657 | $5,047,000 | 3.31% |
| L1 Capital Pty Ltd | 161,163 | $10,474,000 | 2.05% |
| Avoro Capital Advisors LLC | 1,535,000 | $99,760,000 | 1.84% |
| Affinity Asset Advisors, LLC | 100,000 | $6,499,000 | 1.81% |
| GREAT POINT PARTNERS LLC | 95,500 | $6,207,000 | 1.50% |
| ARMISTICE CAPITAL, LLC | 1,236,000 | $80,328,000 | 1.39% |
| Affinity Asset Advisors, LLC | 75,000 | $4,874,000 | 1.36% |
| MPM BioImpact LLC | 44,747 | $2,908,000 | 0.69% |
| Baker Brothers Advisors | 1,499,213 | $97,434,000 | 0.64% |
| Perceptive Advisors | 331,023 | $21,513,000 | 0.62% |